1. Home
  2. FPI vs LXRX Comparison

FPI vs LXRX Comparison

Compare FPI & LXRX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Farmland Partners Inc.

FPI

Farmland Partners Inc.

HOLD

Current Price

$9.76

Market Cap

448.2M

Sector

Real Estate

ML Signal

HOLD

LXRX

Lexicon Pharmaceuticals Inc.

HOLD

Current Price

$1.17

Market Cap

425.2M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
FPI
LXRX
Founded
2013
1995
Country
United States
United States
Employees
N/A
N/A
Industry
Real Estate Investment Trusts
Biotechnology: Pharmaceutical Preparations
Sector
Real Estate
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
448.2M
425.2M
IPO Year
2014
2000

Fundamental Metrics

Financial Performance
Metric
FPI
LXRX
Price
$9.76
$1.17
Analyst Decision
Buy
Analyst Count
0
5
Target Price
N/A
$3.23
AVG Volume (30 Days)
633.0K
1.6M
Earning Date
10-29-2025
11-06-2025
Dividend Yield
2.41%
N/A
EPS Growth
296.76
N/A
EPS
1.27
N/A
Revenue
$52,990,000.00
$70,864,000.00
Revenue This Year
N/A
$56.61
Revenue Next Year
N/A
N/A
P/E Ratio
$7.82
N/A
Revenue Growth
N/A
1255.21
52 Week Low
$9.37
$0.28
52 Week High
$12.87
$1.66

Technical Indicators

Market Signals
Indicator
FPI
LXRX
Relative Strength Index (RSI) 42.96 38.40
Support Level $9.65 $1.12
Resistance Level $10.53 $1.32
Average True Range (ATR) 0.15 0.09
MACD -0.00 -0.01
Stochastic Oscillator 10.63 16.44

Price Performance

Historical Comparison
FPI
LXRX

About FPI Farmland Partners Inc.

Farmland Partners Inc owns and seeks to acquire high-quality farmland throughout North America. The company is an internally managed real estate company which owns and contracts farmland and storage facilities located across the United States. Majority of the properties in its portfolio are used to grow primary crops, such as corn, soybeans, wheat, rice and cotton, and rest to produce specialty crops, such as almonds, pictachios, citrus, avacados, strawberies, and edible beans. The company generates its revenues through the rent it receives from its tenants.

About LXRX Lexicon Pharmaceuticals Inc.

Lexicon Pharmaceuticals Inc is a biopharmaceutical company. It is engaged in the discovery, development, and commercialization of pharmaceutical products for the treatment of human diseases. Some of its drug candidates are LX9211, an orally-delivered small molecule drug candidate, also developing LX9851, an orally-delivered small molecule drug candidate, as a treatment for obesity and associated cardiometabolic.

Share on Social Networks: